newsfilter
← Latest News
Business Wire·

Alpha Cognition Provides CEO Update

Alpha Cognition Inc. (TSXV:ACOG)(OTCQB:ACOGF)("Alpha Cognition", or the "Company"), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, ha